Chimeric Antigen Receptor (CAR) T Cell Therapy With YESCARTA in the Outpatient Setting
Vanderbilt-Ingram Cancer Center
Vanderbilt-Ingram Cancer Center
Federal Research Institute of Pediatric Hematology, Oncology and Immunology
University of Maryland, Baltimore